Yu-Hsiang Hsieh1, Richard E Rothman2, Oliver B Laeyendecker3, Gabor D Kelen1, Ama Avornu1, Eshan U Patel3, Jim Kim1, Risha Irvin4, David L Thomas4, Thomas C Quinn3. 1. Department of Emergency Medicine. 2. Department of Emergency Medicine Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore. 3. Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland. 4. Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore.
Abstract
BACKGROUND: The Centers for Disease Control and Prevention (CDC) recommends 1-time hepatitis C virus (HCV) testing in the 1945-1965 birth cohort, in addition to targeted risk-based testing. Emergency departments (EDs) are key venues for HCV testing because of the population served and success in HIV screening. We determined the burden of undocumented HCV infection in our ED, providing guidance for implementation of ED-based HCV testing. METHODS: An 8-week seroprevalence study was conducted in an urban ED in 2013. All patients with excess blood collected for clinical purposes were included. Demographic and clinical information including documented HCV infection was obtained from electronic medical records. HCV antibody testing was performed on excess samples. RESULTS: Of 4713 patients, 652 (13.8%) were HCV antibody positive. Of these, 204 (31.3%) had undocumented HCV infection. Among patients with undocumented infections, 99 (48.5%) would have been diagnosed based on birth cohort testing, and an additional 54 (26.5%) would be identified by risk-based testing. If our ED adhered to the CDC guidelines, 51 (25.0%) patients with undocumented HCV would not have been tested. Given an estimated 7727 unique ED patients with HCV infection in a 1-year period, birth cohort plus risk-based testing would identify 1815 undocumented infections, and universal testing would identify additional 526 HCV-infected persons. CONCLUSIONS: Birth cohort-based testing would augment identification of undocumented HCV infections in this ED 2-fold, relative to risk-based testing only. However, our data demonstrate that one-quarter of infections would remain undiagnosed if current CDC birth cohort recommendations were employed, suggesting that in high-risk urban ED settings a practice of universal 1-time testing might be more effective.
BACKGROUND: The Centers for Disease Control and Prevention (CDC) recommends 1-time hepatitis C virus (HCV) testing in the 1945-1965 birth cohort, in addition to targeted risk-based testing. Emergency departments (EDs) are key venues for HCV testing because of the population served and success in HIV screening. We determined the burden of undocumented HCV infection in our ED, providing guidance for implementation of ED-based HCV testing. METHODS: An 8-week seroprevalence study was conducted in an urban ED in 2013. All patients with excess blood collected for clinical purposes were included. Demographic and clinical information including documented HCV infection was obtained from electronic medical records. HCV antibody testing was performed on excess samples. RESULTS: Of 4713 patients, 652 (13.8%) were HCV antibody positive. Of these, 204 (31.3%) had undocumented HCV infection. Among patients with undocumented infections, 99 (48.5%) would have been diagnosed based on birth cohort testing, and an additional 54 (26.5%) would be identified by risk-based testing. If our ED adhered to the CDC guidelines, 51 (25.0%) patients with undocumented HCV would not have been tested. Given an estimated 7727 unique ED patients with HCV infection in a 1-year period, birth cohort plus risk-based testing would identify 1815 undocumented infections, and universal testing would identify additional 526 HCV-infected persons. CONCLUSIONS: Birth cohort-based testing would augment identification of undocumented HCV infections in this ED 2-fold, relative to risk-based testing only. However, our data demonstrate that one-quarter of infections would remain undiagnosed if current CDC birth cohort recommendations were employed, suggesting that in high-risk urban ED settings a practice of universal 1-time testing might be more effective.
Authors: Yu-Hsiang Hsieh; Gabor D Kelen; Oliver Laeyendecker; Chadd K Kraus; Thomas C Quinn; Richard E Rothman Journal: Ann Emerg Med Date: 2015-02-23 Impact factor: 5.721
Authors: Bryce D Smith; Rebecca L Morgan; Geoff A Beckett; Yngve Falck-Ytter; Deborah Holtzman; Chong-Gee Teo; Amy Jewett; Brittney Baack; David B Rein; Nita Patel; Miriam Alter; Anthony Yartel; John W Ward Journal: MMWR Recomm Rep Date: 2012-08-17
Authors: Kathleen N Ly; Jian Xing; R Monina Klevens; Ruth B Jiles; John W Ward; Scott D Holmberg Journal: Ann Intern Med Date: 2012-02-21 Impact factor: 25.391
Authors: J Bansal; N T Constantine; X Zhang; J D Callahan; S S Wasserman; V C Marsiglia Journal: Sex Transm Dis Date: 1993 Jul-Aug Impact factor: 2.830
Authors: Christopher E McGowan; Ali Monis; Bruce R Bacon; Josep Mallolas; Fernando L Goncales; Ioannis Goulis; Fred Poordad; Nezam Afdhal; Stefan Zeuzem; Teerha Piratvisuth; Patrick Marcellin; Michael W Fried Journal: Hepatology Date: 2013-04 Impact factor: 17.425
Authors: Maxine M Denniston; Ruth B Jiles; Jan Drobeniuc; R Monina Klevens; John W Ward; Geraldine M McQuillan; Scott D Holmberg Journal: Ann Intern Med Date: 2014-03-04 Impact factor: 25.391
Authors: Caitlin Conrad; Heather M Bradley; Dita Broz; Swamy Buddha; Erika L Chapman; Romeo R Galang; Daniel Hillman; John Hon; Karen W Hoover; Monita R Patel; Andrea Perez; Philip J Peters; Pam Pontones; Jeremy C Roseberry; Michelle Sandoval; Jessica Shields; Jennifer Walthall; Dorothy Waterhouse; Paul J Weidle; Hsiu Wu; Joan M Duwve Journal: MMWR Morb Mortal Wkly Rep Date: 2015-05-01 Impact factor: 17.586
Authors: Benjamin P Linas; Devra M Barter; Jared A Leff; Sabrina A Assoumou; Joshua A Salomon; Milton C Weinstein; Arthur Y Kim; Bruce R Schackman Journal: PLoS One Date: 2014-05-19 Impact factor: 3.752
Authors: Elissa M Schechter-Perkins; Nancy S Miller; Jon Hall; Joshua J Hartman; David H Dorfman; Chris Andry; Benjamin P Linas Journal: Acad Emerg Med Date: 2018-07-20 Impact factor: 3.451
Authors: Yu-Hsiang Hsieh; Danielle Signer; Anuj V Patel; Valentina Viertel; Mustapha Saheed; Risha Irvin; Mark S Sulkowski; David L Thomas; Richard E Rothman Journal: Am J Emerg Med Date: 2018-08-29 Impact factor: 2.469
Authors: Eshan U Patel; Shruti H Mehta; Denali Boon; Thomas C Quinn; David L Thomas; Aaron A R Tobian Journal: Clin Infect Dis Date: 2020-01-16 Impact factor: 9.079
Authors: Eshan U Patel; Oliver Laeyendecker; Yu-Hsiang Hsieh; Richard E Rothman; Gabor D Kelen; Thomas C Quinn Journal: J Clin Virol Date: 2016-05-10 Impact factor: 3.168
Authors: Lucia V Torian; Uriel R Felsen; Qiang Xia; Fabienne Laraque; Eric J Rude; Herbert Rose; Adam Cole; Angelica Bocour; Gary J Williams; Robert F Bridgforth; Lisa A Forgione; Howard Doo; Sarah L Braunstein; Demetre C Daskalakis; Barry S Zingman Journal: Am J Public Health Date: 2018-03-22 Impact factor: 9.308
Authors: Harrys A Torres; Terri Lynn Shigle; Nassim Hammoudi; James T Link; Felipe Samaniego; Ahmed Kaseb; Vincent Mallet Journal: CA Cancer J Clin Date: 2017-07-06 Impact factor: 508.702
Authors: Joshua A Blackwell; Joel B Rodgers; Ricardo A Franco; Stacey S Cofield; Lauren A Walter; James W Galbraith; Erik P Hess Journal: Am J Emerg Med Date: 2019-11-29 Impact factor: 2.469